These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20501856)

  • 21. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
    Moulin S; Llanos S; Kim SH; Peters G
    Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
    J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B23 and ARF: friends or foes?
    Lindström MS; Zhang Y
    Cell Biochem Biophys; 2006; 46(1):79-90. PubMed ID: 16943625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
    Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
    Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
    Gjerset RA
    J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus.
    Gibson SL; Dai CY; Lee HW; DePinho RA; Gee MS; Lee WM; Furth EE; Brensinger C; Enders GH
    Cancer Res; 2003 Feb; 63(4):742-6. PubMed ID: 12591718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I.
    Lessard F; Morin F; Ivanchuk S; Langlois F; Stefanovsky V; Rutka J; Moss T
    Mol Cell; 2010 May; 38(4):539-50. PubMed ID: 20513429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.
    Geng L; Chaudhuri A; Talmon G; Wisecarver JL; Wang J
    PLoS One; 2013; 8(3):e59918. PubMed ID: 23536895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
    Lee S; Cho YE; Kim SH; Kim YJ; Park JH
    Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ARF-B23 connection: implications for growth control and cancer treatment.
    Zhang Y
    Cell Cycle; 2004 Mar; 3(3):259-62. PubMed ID: 14726681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
    Kuo ML; den Besten W; Thomas MC; Sherr CJ
    Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer.
    Johnson SAS; Lin JJ; Walkey CJ; Leathers MP; Coarfa C; Johnson DL
    Oncotarget; 2017 Jul; 8(30):48832-48845. PubMed ID: 28415573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Short N-Terminal Repeats of Transcription Termination Factor 1 Contain Semi-Redundant Nucleolar Localization Signals and P19-ARF Tumor Suppressor Binding Sites.
    Boutin J; Lessard F; Tremblay MG; Moss T
    Yale J Biol Med; 2019 Sep; 92(3):385-396. PubMed ID: 31543703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.
    Rizos H; McKenzie HA; Ayub AL; Woodruff S; Becker TM; Scurr LL; Stahl J; Kefford RF
    J Biol Chem; 2006 Dec; 281(49):38080-8. PubMed ID: 17035234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.